A detailed history of Jump Financial, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 56,652 shares of ITCI stock, worth $4.96 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
56,652
Previous 62,889 9.92%
Holding current value
$4.96 Million
Previous $4.31 Million 3.83%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.99 - $80.84 $424,053 - $504,199
-6,237 Reduced 9.92%
56,652 $4.14 Million
Q2 2024

Aug 14, 2024

BUY
$64.76 - $79.84 $4.07 Million - $5.02 Million
62,889 New
62,889 $4.31 Million
Q4 2023

Oct 21, 2024

SELL
$46.37 - $73.65 $1.95 Million - $3.1 Million
-42,128 Reduced 74.26%
14,600 $1.05 Million
Q4 2023

Feb 07, 2024

SELL
$46.37 - $73.65 $1.95 Million - $3.1 Million
-42,128 Reduced 74.26%
14,600 $1.05 Million
Q3 2023

Oct 21, 2024

BUY
$52.09 - $64.1 $2,760 - $3,397
53 Added 0.09%
56,728 $2.95 Million
Q3 2023

Nov 07, 2023

BUY
$52.09 - $64.1 $2,760 - $3,397
53 Added 0.09%
56,728 $2.95 Million
Q2 2023

Oct 21, 2024

SELL
$54.67 - $66.44 $2.36 Million - $2.87 Million
-43,156 Reduced 43.23%
56,675 $3.59 Million
Q2 2023

Aug 07, 2023

SELL
$54.67 - $66.44 $2.36 Million - $2.87 Million
-43,156 Reduced 43.23%
56,675 $3.59 Million
Q1 2023

Oct 21, 2024

BUY
$43.8 - $56.99 $1.62 Million - $2.11 Million
36,942 Added 58.74%
99,831 $5.41 Million
Q1 2023

May 03, 2023

BUY
$43.8 - $56.99 $2.05 Million - $2.67 Million
46,822 Added 88.33%
99,831 $5.41 Million
Q4 2022

Feb 13, 2023

BUY
$44.07 - $54.45 $1.9 Million - $2.34 Million
43,009 Added 430.09%
53,009 $2.81 Million
Q3 2022

Nov 07, 2022

BUY
$42.7 - $59.99 $427,000 - $599,900
10,000 New
10,000 $465,000
Q4 2020

Feb 12, 2021

SELL
$23.34 - $32.22 $772,950 - $1.07 Million
-33,117 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$17.61 - $31.86 $583,190 - $1.06 Million
33,117 New
33,117 $850,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.27B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.